Lọc tín hiệu
PMC

PMC

Pharmedic Pharmaceutical
PharmaceuticalsHNX
Same sector:AGPAMPBCHBCPBIOCDPCNCDANDBDDBM
123.500
−1,04%
2026-10-19

Fundamental Analysis

37 / 100BRubric: Manufacturing
Quarterly resultsRelative Valuation
CriterionLatest Q EPS growth (YoY)Avg EPS growth, last 3 (YoY)Quarters with EPS growthRevenue growth (YoY)Gross margin change (pp, YoY)Net margin change (pp, YoY)Return on Equity (TTM)Financial health (Debt/Equity)Valuation (P/E vs 5-yr median)Revenue (bn)Rev YoYNPAT (bn)NPAT YoYP/E5-Year Median P/EP/E vs. 5-Year Median
Value-40.0%-16.2%1 / 3-10.0%-0.89 pp-5.63 pp+29.9%0.3415.66119−10,0%13,4−40,0%15.6613.12+19,4%
Pts00404012128
Valuation annotation:Price: 123.500 (close price on 2026-10-19)EPS (TTM): 7.885

Financial charts

1.Revenue & growth

VND bn119Q2/26

1.Revenue & growth

VND bn119Q2/26

2.Profit & growth

VND bn13,4Q2/26

3.Profit mix (Penman)

VND bn92,1Q2/26

4.Margins & cost structure

%40.8%Q2/26

5.Returns & cash cycle

% · days31.8%Q2/26

6.Earnings quality & cash

VND bn14,4Q2/26

7.Asset structure

VND bn413Q2/26

8.Funding & debt health

VND bn · times413Q2/26

9.Revenue backlog

VND bn1,68Q2/26

10.Valuation

times · %15,7×Q2/26

11.EPS growth & dilution warning (CANSLIM)

VND per share; growth in %1.438Q2/26
Adjusted EPS growth, latest quarter
-40.0%
Average adjusted EPS growth, 3 quarters
-16.2%
Quarters at 25%+ growth
0/3
Share dilution rate, 1 year
0.0%

Source: vnstockData through Q2/26